Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 1992. Upgrade now.
Date Value
September 30, 2024 3.319B
June 30, 2024 3.184B
March 31, 2024 3.930B
December 31, 2023 3.668B
September 30, 2023 4.359B
June 30, 2023 3.004B
March 31, 2023 2.527B
December 31, 2022 3.398B
September 30, 2022 4.148B
June 30, 2022 7.869B
March 31, 2022 7.936B
December 31, 2021 6.529B
September 30, 2021 5.381B
June 30, 2021 1.694B
March 31, 2021 2.029B
December 31, 2020 2.004B
September 30, 2020 1.582B
June 30, 2020 2.425B
March 31, 2020 1.706B
December 31, 2019 2.000B
September 30, 2019 1.995B
June 30, 2019 1.906B
March 31, 2019 2.095B
December 31, 2018 1.812B
September 30, 2018 1.628B
Date Value
June 30, 2018 1.636B
March 31, 2018 1.268B
December 31, 2017 1.034B
September 30, 2017 815.17M
June 30, 2017 992.46M
March 31, 2017 1.339B
December 31, 2016 974.00M
September 30, 2016 838.08M
June 30, 2016 1.052B
March 31, 2016 809.63M
December 31, 2015 652.85M
September 30, 2015 629.44M
June 30, 2015 -32.77M
March 31, 2015 214.84M
December 31, 2014 419.43M
September 30, 2014 551.55M
June 30, 2014 527.76M
March 31, 2014 355.93M
December 31, 2013 432.27M
September 30, 2013 297.54M
June 30, 2013 224.15M
March 31, 2013 39.19M
December 31, 2012 -123.95M
September 30, 2012 -263.58M
June 30, 2012 -306.58M

Free Cash Flow Range, Past 5 Years

1.582B
Minimum
Sep 2020
7.936B
Maximum
Mar 2022
3.635B
Average
3.252B
Median

Free Cash Flow Benchmarks

Amgen Inc 6.283B
Eli Lilly and Co -2.275B
Pfizer Inc 8.227B
Biogen Inc 1.768B
AbbVie Inc 15.62B